3,4-dihydroxyphenylacetaldehyde has been researched along with Hypotension, Orthostatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, CP; Feng, Y; Gao, S; He, C; Li, BY; Li, KX; Qiao, GF; Sun, J; Sun, X; Wang, HD; Wang, X; Xiong, X; Yan, QX; Yin, RX; Zha, RR | 1 |
| Goldstein, DS; Heredia-Moya, J; Holmes, C; Whittaker, N | 1 |
2 other study(ies) available for 3,4-dihydroxyphenylacetaldehyde and Hypotension, Orthostatic
| Article | Year |
|---|---|
Parkinson-like early autonomic dysfunction induced by vagal application of DOPAL in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Synuclein; Animals; Autonomic Nervous System Diseases; Baroreflex; Blood Pressure; Electrocardiography; Hypotension, Orthostatic; Male; Mitochondria, Heart; Myocardium; Myocytes, Cardiac; Nodose Ganglion; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Vagus Nerve | 2021 |
Contamination of the norepinephrine prodrug droxidopa by dihydroxyphenylacetaldehyde.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Aged, 80 and over; Antiparkinson Agents; Chromatography, Liquid; Droxidopa; Drug Contamination; Female; Humans; Hypotension, Orthostatic; Male; Middle Aged; Parkinson Disease | 2010 |